Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

LEMAITRE VASCULAR, INC.

(LMAT)
  Report
Delayed Nasdaq  -  04:00 2022-11-29 pm EST
45.23 USD   +1.32%
11/22LeMaitre to Present at Upcoming Investor Conferences
AQ
11/16LEMAITRE VASCULAR, INC. : Ex-dividend day for
FA
11/08LEMAITRE VASCULAR INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Days
:
Hours
:
Minutes
:
Seconds

LeMaitre: 4Q Earnings Snapshot

02/06/2020 | 05:27pm EST

BURLINGTON, Mass. (AP) _ LeMaitre Vascular Inc. (LMAT) on Thursday reported fourth-quarter net income of $4.6 million.

On a per-share basis, the Burlington, Massachusetts-based company said it had net income of 23 cents.

The results matched Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was also for earnings of 23 cents per share.

The medical device maker posted revenue of $30.2 million in the period, missing Street forecasts. Three analysts surveyed by Zacks expected $30.5 million.

For the year, the company reported profit of $17.9 million, or 88 cents per share. Revenue was reported as $117.2 million.

For the current quarter ending in April, LeMaitre expects its per-share earnings to range from 14 cents to 17 cents.

The company said it expects revenue in the range of $30.5 million to $31.7 million for the fiscal first quarter.

LeMaitre expects full-year earnings in the range of 90 cents to 98 cents per share, with revenue ranging from $127.4 million to $130.8 million.

LeMaitre shares have increased 1% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $36.39, a rise of 53% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on LMAT at https://www.zacks.com/ap/LMAT

Automated Insights, source Associated Press News

All news about LEMAITRE VASCULAR, INC.
11/22LeMaitre to Present at Upcoming Investor Conferences
AQ
11/16LEMAITRE VASCULAR, INC. : Ex-dividend day for
FA
11/08LEMAITRE VASCULAR INC Management's Discussion and Analysis of Financial Condition and ..
AQ
11/02LeMaitre to Present at Upcoming Investor Conferences
AQ
10/31North American Morning Briefing: Futures Pull -3-
DJ
10/28Barrington Research Downgrades LeMaitre Vascular to Market Perform From Outperform
MT
10/27Lemaitre : Q3 Earnings Snapshot
AQ
10/27Transcript : LeMaitre Vascular, Inc., Q3 2022 Earnings Call, Oct 27, 2022
CI
10/27LeMaitre Vascular, Inc. Reports Earnings Results for the Third Quarter and Nine Months ..
CI
10/27Earnings Flash (LMAT) LEMAITRE VASCULAR Reports Q3 Revenue $39M
MT
More news
Analyst Recommendations on LEMAITRE VASCULAR, INC.
More recommendations
Financials (USD)
Sales 2022 162 M - -
Net income 2022 20,7 M - -
Net Debt 2022 - - -
P/E ratio 2022 48,6x
Yield 2022 1,11%
Capitalization 995 M 995 M -
Capi. / Sales 2022 6,15x
Capi. / Sales 2023 5,75x
Nbr of Employees 469
Free-Float 82,2%
Chart LEMAITRE VASCULAR, INC.
Duration : Period :
LeMaitre Vascular, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends LEMAITRE VASCULAR, INC.
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Last Close Price 45,23 $
Average target price 58,83 $
Spread / Average Target 30,1%
EPS Revisions
Managers and Directors
George W. LeMaitre Chairman & Chief Executive Officer
David B. Roberts Chief Financial Officer
Joseph P. Pellegrino Chief Financial Officer, Secretary & Director
Jonathan W. Ngau Director-Information Technology
Ryan H. Connelly Vice President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
LEMAITRE VASCULAR, INC.-8.10%982
THERMO FISHER SCIENTIFIC-19.07%212 798
DANAHER CORPORATION-20.62%190 115
INTUITIVE SURGICAL, INC.-26.21%92 813
BOSTON SCIENTIFIC CORPORATION3.93%62 721
SIEMENS HEALTHINEERS AG-22.64%59 129